At IDT Biologika, we are an international leader in the field of biotechnology, a key global technology for the 21st century. Our 95-year tradition of manufacturing vaccines and pharmaceuticals motivates and obligates us to continue our work in improving the health of humans and animals, now and going forward. Today, our company ranks among the top echelon of innovative high-tech life science companies, delivering a consistent level of quality in the standardized production of biopharmaceuticals. We have achieved this position through our commitment to employing highly qualified staff, using state-of-the-art production technologies, and strongly investing in research and development.
Award-winning innovation and quality — IDT focuses on contract manufacturing for human and animal health. IDT Biologika has received international accolades for the development and manufacturing of new vaccines.
New building for vaccine production enables even more flexible reaction to customer demands more info
Ceva completes acquisition of IDT veterinary business assets, moving closer to its 2020 objective of 50:50 bio-pharma split more info
Divestment of animal health business unit enables focus on global growth market more info
Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portfolio and boosting swine innovation more info
RT @IMG_ST: Last Friday a multifunctional production facility for human virus production was inaugurated at the #Biopharmapark in #SaxonyAn… more info
RT @iitoLifeScience: IDT Biologika to Divest Animal Health Business Unit to Focus on Production of Human Vaccines & Medicines https://t.co/… more info
RT @CevaSanteAnimal: [Press Release] 📣 Ceva is proud to announce provisional agreement to acquire the animal health business of biopharmac… more info